Drug class
Steroidal-structure antibiotic; elongation factor G (EF-G) inhibitor
Mechanism of action
Binds bacterial elongation factor G (EF-G) and prevents its release from the ribosome after translocation, inhibiting protein synthesis and bacterial growth.
General use cases
- Topical treatment of localised bacterial skin infections caused by susceptible Staphylococcus aureus, including impetigo and infected dermatitis, with authorised topical formulations
- Systemic treatment of serious susceptible staphylococcal infections in selected jurisdictions and formulations; topical and systemic indications are not interchangeable
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
